US 9169495
Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
granted A61KA61K2039/523A61K39/3955
Quick answer
US patent 9169495 (Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells) held by EnGeneIC Molecular Delivery Pty Ltd expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- EnGeneIC Molecular Delivery Pty Ltd
- Grant date
- Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/523, A61K39/3955, A61K47/6901, A61K48/00